首页> 美国卫生研究院文献>ACS AuthorChoice >A Radiofluorinated Divalent Cystine Knot Peptide forTumor PET Imaging
【2h】

A Radiofluorinated Divalent Cystine Knot Peptide forTumor PET Imaging

机译:放射性氟化二价胱氨酸结肽肿瘤PET成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A divalent knottin containing two separate integrin binding epitopes (RGD) in the adjacent loops, 3-4A, was recently developed and reported in our previous publication. In the current study, 3-4A was radiofluorinated with a 4-nitrophenyl 2-18F-fluoropropinate (18F-NFP) group and the resulting divalent positron emission tomography (PET) probe, 18F-FP–3-4A, was evaluated as a novel imaging probe to detect integrin αvβ3 positive tumors in living animals. Knottin 3-4A was synthesized by solid phase peptide synthesis, folded, and site-specifically conjugated with 18/19F-NFP to produce the fluorinated peptide 18/19F-fluoropropinate-3-4A (18/19F-FP–3-4A). The stability of 18F-FP–3-4A was tested in both phosphate buffered saline (PBS) buffer and mouse serum. Cell uptake assays of the radiolabeled peptides were performed using U87MG cells. In addition, small animal PET imaging and biodistribution studies of 18F-FP–3-4A were performed in U87MG tumor-bearing mice. The receptor targeting specificity of the radiolabeled peptide was also verified by coinjecting the probe with a blocking peptide cyclo(RGDyK). Our study showed that 18F-FP–3-4A exhibited excellent stability in PBS buffer (pH 7.4) and mouse serum. Small animal PET imaging and biodistributiondata revealed that 18F-FP–3-4A exhibited rapid andgood tumor uptake (3.76 ± 0.59% ID/g and 2.22 ± 0.62% ID/gat 0.5 and 1 h, respectively). 18F-FP–3-4A was rapidlycleared from the normal tissues, resulting in excellent tumor-to-normaltissue contrasts. For example, liver uptake was only 0.39 ± 0.07%ID/g and the tumor to liver ratio was 5.69 at 1 h p.i. Furthermore,coinjection of cyclo(RGDyK) with 18F-FP–3-4A significantlyinhibited tumor uptake (0.41 ± 0.12 vs 1.02 ± 0.19% ID/gat 2.5 h) in U87MG xenograft models, demonstrating specific accumulationof the probe in the tumor. In summary, the divalent probe 18F-FP–3-4A is characterized by rapid and high tumor uptakeand excellent tumor-to-normal tissue ratios. 18F-FP–3-4Ais a highly promising knottin based PET probe for translating intoclinical imaging of tumor angiogenesis.
机译:最近开发了在相邻环中包含两个独立的整合素结合表位(RGD)的二价结蛋白3-4A,并在我们以前的出版物中进行了报道。在目前的研究中,使用4-硝基苯基2- 18 F-氟丙酸酯( 18 F-NFP)基团对3-4A进行放射性氟化,得到的二价正电子发射断层显像( PET)探针 18 F-FP–3-4A被评估为检测活体动物整联蛋白αvβ3阳性肿瘤的新型成像探针。通过固相肽合成法合成Knottin 3-4A,折叠后与 18/19 F-NFP特异性结合,生成氟化肽 18/19 F-氟丙酸酯-3-4A( 18/19 F-FP–3-4A)。在磷酸盐缓冲液(PBS)缓冲液和小鼠血清中测试了 18 F-FP–3-4A的稳定性。使用U87MG细胞进行放射性标记肽的细胞摄取测定。此外,在U87MG荷瘤小鼠中进行了 18 F-FP–3-4A的小动物PET成像和生物分布研究。还通过将探针与封闭肽环(RGDyK)共注射来验证放射性标记肽的受体靶向特异性。我们的研究表明 18 F-FP–3-4A在PBS缓冲液(pH 7.4)和小鼠血清中表现出优异的稳定性。小动物PET成像和生物分布数据显示 18 F-FP–3-4A表现出快速的良好的肿瘤吸收(3.76±0.59%ID / g和2.22±0.62%ID / g分别在0.5和1小时)。 18 F-FP–3-4A迅速从正常组织清除,导致极佳的肿瘤至正常组织对比。例如,肝脏摄取仅为0.39±0.07%ID / g和p / i在1 h时肿瘤与肝脏的比率为5.69。此外,环(RGDyK)与 18 F-FP–3-4A的共注射抑制肿瘤吸收(0.41±0.12 vs 1.02±0.19%ID / g在U87MG异种移植模型中2.5 h时),表明了特定的积累探针在肿瘤中的位置。综上所述,二价探针 18 F-FP–3-4A的特点是肿瘤摄取迅速且高以及出色的肿瘤与正常组织比率。 18 F-FP–3-4A是一种很有前途的基于结蛋白的PET探针,可翻译成肿瘤血管生成的临床影像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号